Adverum Biotechnologies (ADVM) Stock Highlights

4.74 | +0.85%

2024-12-21 06:29:25

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections.

Statistics

Range Today

4.61 4.89

Volume Today 276.1K

Range 1 Year

4.66 29.7

Volume 1 Year 68.12M

Range 3 Year

4.66 29.7

Volume 3 Year 102.44M

Range 10 Year

4.66 624.8

Volume 10 Year 259.1M

Highlights

Market Capitalization 166.42M (small)

Floating Shares 12.59M

Current Price 4.74

Price To Earnings -1.31

Price To Revenue 86.44

Price To Book 1.15

Earnings Per Share -6.03

Payout Ratio 0%

Performance

Latest +0.85%

1 Month -24.28%

3 Months -36.12%

6 Months -27.85%

1 Year -39.23%

3 Years -73.67%

5 Years -95.7%

10 Years -99.08%

Benchmarks

Market Capitalization

225 / 368

Gross Profits

0 / 278

Total Revenue

211 / 300

Total Rank

236 / 368

Free Cashflow

218 / 352

Performance 5 years

324 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.